Effects of an Exercise Program on Physiological Functions in Postmenopausal Women with Metabolic Syndrome  by Valkeinen, Heli et al.
lable at ScienceDirect
International Journal of Gerontology 7 (2013) 231e235Contents lists avaiInternational Journal of Gerontology
journal homepage: www.i jge-onl ine.comBrief CommunicationEffects of an Exercise Program on Physiological Functions in
Postmenopausal Women with Metabolic Syndromeq
Heli Valkeinen 1*, Ihab Hajjar 2, Kun Hu 3, Brad Manor 4, Jessica Wisocky 5, Vera Novak 4
1National Institute for Health and Welfare, Helsinki, Finland, 2Department of Medicine, University of Southern California, Los Angeles, CA, 3Medical
Biodynamics Program, Division of Sleep Medicine, Brigham and Women’s Hospital, Harvard Medical School, 4Division of Gerontology, Beth Israel Deaconess
Medical Center, Harvard Medical School, 5Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAa r t i c l e i n f o
Article history:
Received 5 February 2013
Received in revised form
17 April 2013
Accepted 17 May 2013
Available online 20 November 2013
Keywords:
blood ﬂow velocity,
executive function,
exercise,
metabolic syndrome X,
oxygen consumptionq The authors declare no potential conﬂicts of i
research, authorship, and/or publication of this articl
* Correspondence to: Dr Heli Valkeinen, Nation
Welfare, P.O. Box 30, Fin-00271 Helsinki, Finland.
E-mail address: heli.valkeinen@thl.ﬁ (H. Valkeinen
1873-9598/$ e see front matter Copyright  2013, Ta
http://dx.doi.org/10.1016/j.ijge.2013.05.002s u m m a r y
The purpose of this study was to examine the effects of a mixed interval aerobic and strength training
(MAST) program on physiological functions in older women with metabolic syndrome. A total of 12
participants were randomly assigned to the exercise group (16-week MAST program) or the control
group. Outcomes included oxygen uptake (VO2max), cerebral blood ﬂow velocity (BFV), and cognitive
functions. The exercise group demonstrated increased VO2max and certain improvements in cognitive
functions. No changes were observed in BFV for both groups. These results can be used as preliminary
data for planning larger studies.
Copyright  2013, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Metabolic syndrome (MetS) is a combination of adverse condi-
tions and disorders that increase the risk for cardiovascular dis-
eases and diabetes1. MetS may also be associated with cognitive
decline in physically inactive older women2 who are at risk for
decreased physical functioning due to age- and inactivity-related
decrease of muscle strength and mass3 as well as decreased aero-
bic capacity (VO2max)4.
Aerobic exercise and combined aerobic and strength training
have positive effects on physical ﬁtness and cardiovascular risk
factors in patients with MetS5e8. Long-term regular physical ac-
tivity and improved aerobic capacity may also contribute to im-
provements in cognitive functions in healthy adults9. Previous
studies have mainly focused on high-intensity interval training
(>85% of maximal heart rate), and less is known about the effects of
low-intensity interval training on health10. MetS is associated with
cognitive decline2 and high body mass index (BMI) is associated
with a reduction in cerebral blood ﬂow velocity (BFV)11. Thus, it
could be possible that obese patients with MetS have reduced BFVnterest with respect to the
e.
al Institute for Health and
).
iwan Society of Geriatric Emergenand also declined cognitive functions12. However, it is unknown
whether regular exercise could improve cognitive function and also
cerebral BFV in older women with MetS. Thus, the purpose of this
pilot study was to determine the potential effects of a supervised
mixed aerobic (low-intensity interval) and strength training
(MAST) program on aerobic capacity, cognitive function, and ce-
rebral BFV in older women with MetS.2. Methods
2.1. Patients
We conducted a 16-week randomized controlled trial with a
parallel-group design of sedentary womenwith MetS. The Internal
Review Board of Beth Israel Deaconess Medical Center (Boston, MA,
USA) approved the study protocol and all participants gave their
written informed consent.
The inclusion criteria were: (1) postmenopausal female; (2)
age  50 years; (3) MetS deﬁned as central obesity (waist
circumference  88 cm); and (4) at least two of the following four
factors according of Alberti et al1: elevated triglycerides, reduced
high-density lipoprotein cholesterol, elevated blood pressure (BP)
or treated for hypertension, and raised fasting plasma glucose or
treated for diabetes. The participants were allowed to take their
cholesterol and BP medication during the study.cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
H. Valkeinen et al.232Exclusion criteria were: (1) any acute medical condition; (2) a
positive exercise stress test for cardiac ischemia; (3) myocardial
infarction or surgery within 6 months; (4) history of stroke, liver or
renal failure, dementia, or carotid stenosis > 50%; (5) insulin-
dependent diabetes mellitus or type II diabetes if treated with insu-
lin; (6) systolic BP> 180 and/or diastolic BP> 110mmHg; (7) anemia
(Hb < 10); (8) BMI > 45; (9) movement-limiting hip, knee, or back
injury; (10) rheumatoid arthritis; (11) an inability to obtain approval
for participation from the patient’s primary care physician; and (12)
poor middle cerebral artery insonation window or BFV signal.
We recruited participants from the greater Boston community
by advertisements. Of 97 women, who responded to the phone
screen, 12 met all criteria and agreed to participate in the study
(Fig. 1). They were randomly allocated into either the MAST (n ¼ 8)
or control (n ¼ 4) groups. Two participants from the MAST group
were excluded during screeningdone because of gastric bypass
surgery and the other one withdrew consent. Two additional par-
ticipants from the MAST group withdrew consent during exercise
period due to personal reasons and scheduling difﬁculties.2.2. Intervention
TheMASTsessionswere held two times aweek for 16weeks. Each
exercise session consisted of 10minutes of warm-up,15e30minutesRandomization 
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Fig. 1. Flow chart of the study arrangement. BMI ¼ body mass indeof interval aerobic training by cycle ergometer according to the pro-
gram (CorusFit Exercise Assistant; CorusFit Inc., Jyväskylä, Finland),
20minutesof strength trainingexercises, and10minutesof cooldown
by stretching. The target heart rate increased progressively from 50%
up to 80% of heart rate reserve by the end of the intervention period.
The Karvonen formulad[(HRmax  HRrest)  (0.50 to
0.80)] þ HRrestdwas used to calculate the target heart rates. During
every training session the participants used a new wireless comput-
erized electrocardiograph monitoring system (WiEKG T30; CorusFit
Inc.).
After aerobic training, the strength training program was per-
formed (CorusFit Exercise Assistant). Exercises used body mass as
resistance and included the squat, step-up squat, step-up, heel rise,
and sit-ups. The participants used dumb-bells as an extraweight (5%
or 10% of bodyweight) during other exercises except for sit-ups. The
control group participated in an educational session once a month
and kept physical activity diaries during the intervention period.2.3. Laboratory tests and anthropometry
A fasting blood draw was completed to measure blood glucose,
total cholesterol, triglycerides, and high- and low-density lipopro-
tein cholesterol. Body weight (kg), height (cm), and waistention 
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x; PCP ¼ primary care physician; TCD ¼ transcranial Doppler.
Table 1
Disease history and medications in the exercise and control groups.
Training group Control group
(n ¼ 6) (n ¼ 4)
Age (y) 63.3  9.6 55.8  6.1
Disease history
Type II diabetes (n) 3 1
Hypercholesterolemia 5 2
Hypertension (n) 3 2
Osteoporosis (n) 2 0
Asthma (n) 0 1
Hypothyroidism (n) 2 1
Fibromyalgia (n) 2 1
Medications
Antiplatelets (n) 3 0
Antidepressants (n) 2 1
Antihyperlipidemic (n) 5 2
ACE inhibitors (n) 3 0
Antidiabetes (n) 3 1
Mean  standard deviation unless otherwise indicated.
ACE ¼ angiotensin-converting enzyme.
Exercise in Metabolic Syndrome 233circumference (cm) measurements were recorded. These measures
were taken before and after the 16-week intervention period.
2.4. Exercise stress test
To obtain peak oxygen uptake (VO2max), a symptom-limited
exercise stress test was performed on a cycle ergometer (Corival
Cycle Ergometer; Medical Graphics Co., St. Paul, MN, USA). The test
was preceded by a 2-minute warm-up at an intensity of 20 W. The
ﬁrst test load was 20 W, and was increased by 20 W at each 2-
minute stage until the participants could no longer continue, that
is, they were unable tomaintain pedaling frequency> 40 rpm, they
achieved a respiratory-exchange ratio of more than 1.0, or clinical
criteria for test termination was observed. Heart rate, work load
(W), BP, and rating of perceived exertion (using Borg Scale) were
recorded. VO2max was measured and monitored with a breath-by-
breath gas-exchange system (MedGraphics CPX/D Breath-by-
Breath Gas Exchange System; Medical Graphics Co., St. Paul, MN,
USA).
2.5. Cognitive functions
The trail-making (TM) test was performed, and scores in Part A
(TM-A), Part B (TM-B), and their difference (TM-B e TM-A) were
calculated and used to measure executive function, with lower
scores indicating better performance. Digit span (forward and
backward subtests) was used to assess immediate memory and
attention.
2.6. Cerebral blood ﬂow
Cerebral BFV was monitored using transcranial Doppler ultra-
sound (PMD-150; Spencer Technologies, Inc., Seattle, WA 98122,
USA).11 The middle cerebral artery was insonated from the tem-
poral window by placing the 2-MHz probe against the skin of the
temporal region above the zygomatic arch. The probe was posi-
tioned to obtain maximal BFV and was ﬁxed at the desired angle
using a three-dimensional positioning system. Once instrumented,
BFV was continuously recorded throughout the 10 minutes of su-
pine rest and 10minutes on a table tilted to 80 from the horizontal
position (head-up with foot plate support).
2.7. Statistical analysis
Standard statistical methods were used to calculate means and
standard deviations (mean  standard deviation). To examine
group differences in outcomes at baseline, the nonparametric two-
way Wilcoxon rank sum test was used. To examine the impact of
the intervention and its interaction with the study groups, the
nonparametric Wilcoxon signed-rank test (within participants)
and Wilcoxon rank sum test (between a participant and intention-
to-treat principle) were used to analyze the results. In addition,
the effect size was calculated to describe the magnitude of a
treatment effect. A p value < 0.05 was considered to be statisti-
cally signiﬁcant. The JMP statistical program (JMP statistical pro-
gram; SAS Institute Inc., Cary, NC, USA) was used for statistical
analysis.
3. Results
The demographic characteristics are shown in Table 1. All
measures showed no signiﬁcant group difference at baseline
(Table 2). The MAST group completed an average of 20 out of 32
training sessions (62.0%; range 15.6e90.6%). The control group
completed all (100%) educational sessions.The intention-to-treat method showed that after 16 weeks the
participants assigned to the MAST group had an increase in VO2max
of 2.3  7.6%, whereas the control group had a decrease of
8.3  5.1%. The between group difference in the change of VO2max
was signiﬁcant (p¼ 0.042). However, the change within each group
did not reach signiﬁcant level (p > 0.05; Table 2).
In theMASTgroup, therewas a trend for an improvement in TM-
A (17.8  13.0%) and TM-B (23.6  20.5%), that is, they per-
formed the tests faster than at baseline (Table 2). However, within
and between the groups, the change did not reach statistical sig-
niﬁcance (Table 2). Those participants in the MAST group, who
showed increased VO2max also, had improved trends in TM-B-A and
digit span backward results (data not shown). In the control group,
however, no signiﬁcant changes were observed.
As shown in Table 2, there were no signiﬁcant changes in mean
BFV within or between the groups. The mean BFV in the middle
cerebral artery increased in one MAST participant, but decreased in
the other three MAST participants (Table 2).
4. Discussion
The supervised 16-week MAST program improved VO2max in
older women with MetS. The results also showed trends toward
cognitive improvement, yet no change in cerebral BFV.
The improved VO2max in the exercise group was achieved by a
relatively small amount of interval aerobic training as during one
session only 20e30 minutes was used for it. In earlier studies,
VO2max has improved by 9e35% after the 16 weeks of different
aerobic interval training periods 6,7. However, the current amount
of training was not enough to improve, but maintain, the levels of
other health parameters. Recently, low-intensity interval training
has shown to have some beneﬁcial effects on physical ﬁtness and it
may be a potential training mode for patients, but more informa-
tion is still needed10.
Improved cardiorespiratory ﬁtness is beneﬁcial for cognitive
functions9. The current results showed a trend of improved per-
formance in cognitive tests with increased VO2max, although no
such effect was observed in mean BFV of middle cerebral artery. It
is possible that some beneﬁcial effects occurred in the cardiovas-
cular system, such as decreased inﬂammation, but this was not
measured 12. A learning effect may also affect the cognitive test
results.
Table 2
Results of anthropometry, serum glucose and lipids, physical performance, cognitive tests, and cerebral blood ﬂow velocity at baseline and after the 16-week mixed interval
aerobic and strength training period in older women with metabolic syndrome.
Baseline (week 0) Week 16 Change % Effect sizea p*
Ex (n ¼ 6) Cont (n ¼ 4) Ex (n ¼ 6) Cont (n ¼ 4) Ex (n ¼ 6) Cont (n ¼ 4)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean1 (SD1) Mean2 (SD2) 0 versus 16
Anthropometry
Weight (kg) 77.0  14.1 90.2  22.1 78.5  15.4 89.0  19.5 1.7  2.4 0.7  5.5 1.21 0.593
BMI 30.8  3.9 34.9  6.2 31.3  4.5 34.4  5.6 1.5  2.3 1.2  5.3 1.39 0.450
Waist circumference (cm) 101.8  9.6 111.2  20.8 104.0  12.0 106.9  16.4 2.0  3.5 3.4  3.9 2.81 0.109
Serum glucose and lipids
Blood glucose (mmol/L) 7.3  1.3 6.4  2.1 7.2  1.2 6.5  1.2 0.6  2.1 4.3  14.4 1.71 0.336
Total cholesterol (mmol/L) 4.5  1.2 5.9  1.0 5.1  1.6 5.2  1.4 12.4  13.7 11.0  18.1 5.87 0.069
HDL cholesterol (mmol/L) 1.1  0.2 1.3  0.5 1.1  0.2 1.2  0.5 2.2  7.3 2.0  17.0 1.20 0.593
LDL cholesterol (mmol/L) 2.4  1.0 3.8  1.2 3.0  1.4 3.2  1.4 20.3  24.9 17.7  22.6 7.80 0.069
Triglycerides (mmol/L) 2.3  1.1 1.7  0.8 2.3  0.9 1.8  0.7 6.3  13.5 12.2  39.8 1.14 0.915
Physical performance
Peak VO2 (max; mL/kg/min) 18.3  3.8 15.8  5.0 18.6  3.7 14.4  4.4 2.3  7.6 8.3  5.1 4.21 0.042
Work load (max; W) 96.7  19.7 95.0  19.1 103.3  23.4 90.0  25.8 7.5  15.8 6.3  12.5 3.67 0.211
Exercise time (max; s) 546.7  92.6 516.0  90.6 566.8  147.1 456.3  141.6 3.9  15.4 12.4  17.4 4.02 0.165
Cognitive tests
Trail making A (s) 29.1  10.9 31.2  9.3 24.9  7.7 29.7  15.9 11.9  13.6 7.4  25.2 1.02 0.748
Trail making B (s) 78.4  22.7 64.9  31.8 65.6  23.0 59.8  14.8 15.7  20.0 0.0  24.5 3.33 0.336
Trail making B-A (s) 49.3  19.2 33.7  22.9 40.8  21.2 30.2  2.6 15.2  29.6 17.2  55.7 4.96 0.240
Digit span forward 10.3  1.0 9.3  3.8 11.5  2.3 9.8  3.9 10.7  13.6 5.1  24.9 1.28 0.746
Digit span backward 7.2  1.7 7.5  4.2 8.2  2.1 7.3  2.5 18.8  45.3 7.8  29.8 1.80 0.914
Mean BFV of MCA (cm/s)
Baseline (supine) 37.4  11.7 41.7  31.9b 34.7  15.8 33.9  15.7b 4.1  69.6 6.5  24.8 1.54 0.697
Tilt (standing) 33.3  7.4 36.7  26.3b 33.2  16.0 37.8  5.4b 8.0  73.5 8.2  41.0 2.14 0.897
* Wilcoxon using the changes (intention-to-treat).
BFV¼ blood ﬂow velocity; BMI¼ bodymass index; Cont¼ control group; Ex¼ exercise group; HDL¼ high-density lipoprotein; LDL¼ low-density lipoprotein; MCA¼middle
cerebral artery; SD ¼ standard deviation; VO2 ¼ oxygen uptake.
a Effect size ¼ (Mean1eMean2)/[root mean square(SD1 þ SD2/2)].
b n ¼ 3.
H. Valkeinen et al.234The main limitation of the study was the difﬁculty in recruiting
older womenwith MetS. We screened 97 womenwhowere willing
to participate in the study. However, the inclusion/exclusion
criteria were deﬁned quite strictly as these patients usually have
several health problems. The strict criteria may be one reason for
the difﬁculty in enrolling eligible participants. In addition, several
eligible older women refused to participate due to the required
time commitment and transportation difﬁculties13, and we had to
interrupt the recruitment process due to time constraints, and
therefore, our sample size remained small resulting in an unequal
number of participants between the groups. Taking into account
these limitations, the results should be interpreted with caution.
Despite the small sample size, the strengths of the study include
the measurements used, the study design, and the carefully carried
out intervention period. These results may be suitable for use as a
preliminary data for planning larger studies that are examining the
effects of regular exercise on cognitive functions and cerebral BFV
in patients with MetS. In conclusion, the results suggest that even
rather small amounts of regular MAST may maintain aerobic ca-
pacity in older women with MetS. Regular exercise may also posi-
tively affect cognitive functions in these patients, but this
assumption and the possible beneﬁcial changes in cerebral BFV
need to be conﬁrmed in larger studies.Acknowledgments
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